Cargando…
Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies
Radical treatment of malignant solid tumors should aim to be less traumatic, precise, and effective. OncoCiDia, as a noninvasive, sequential dual-targeting, small-molecule, broad spectrum anticancer theranostic approach, may fulfill these requirements of solid cancer (Onco) treatment with both tumor...
Autores principales: | Li, Yue, Wang, Shuncong, Chen, Lei, Feng, Yuanbo, Shen, Zhijun, Chen, Xin, Huang, Gang, Ni, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647265/ https://www.ncbi.nlm.nih.gov/pubmed/36344243 http://dx.doi.org/10.1177/15330338221136716 |
Ejemplares similares
-
A Review of Hedgehog Signaling in Radioresistant Esophageal Cancer:
Potential Treatment Target
por: Ma, Li, et al.
Publicado: (2023) -
Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies
por: Li, Yang, et al.
Publicado: (2023) -
Predictive Value of FNA-Tg and TgAb in Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma
por: Wu, Xiaoli, et al.
Publicado: (2022) -
Isatuximab in the Treatment of Multiple Myeloma: A Review and
Comparison With Daratumumab
por: Shen, Fei, et al.
Publicado: (2022) -
Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency
por: Jiang, Zong-Yuan, et al.
Publicado: (2022)